STOCKS TELEGRAPH

Tag: CETX stock

  • Analyzing The Phenomenal Rise Of Cemtrex (CETX) Stock

    Analyzing The Phenomenal Rise Of Cemtrex (CETX) Stock

    Cemtrex, Inc. (NASDAQ: CETX) experiences a remarkable surge in share value during the current trading session, rising by 21.53% to $4.29 on US stock charts. This development attracts investor and analyst attention, despite no significant news accompanying the increase. The surge underscores the company’s performance, prompting further analysis to understand its underlying strength.

    Cemtrex (CETX) recently secured $2.1 million in fresh orders through its Advanced Industrial Services (“AIS”) subsidiary, underscoring the company’s robust market position and optimistic growth trajectory.

    These orders encompass a $1.6 million contract for two relocation projects from a prominent printing and graphics firm, and a $0.5 million contract for the removal of existing equipment for an engineering and construction entity.

    These orders reaffirm AIS’s commitment to delivering excellence across its spectrum of services. Expected to conclude within the current fiscal year, these projects will leverage AIS’s comprehensive array of services, encompassing mechanical, electrical, piping, and project management expertise.

    This approach not only highlights AIS’s capability to manage intricate industrial demands but also solidifies its stature as a preferred partner within the industry. Owing to confidentiality agreements, specifics regarding the clients were not disclosed.

    AIS consistently secures orders from leading corporations, establishing a growth pipeline that Cemtrex anticipates will culminate in a record-breaking revenue year for the company in 2024.

    AIS’s proficiency in plant and equipment erection, relocation, and disassembly appeals to a diverse range of firms nationwide, facilitating such projects. In recent years, companies have increasingly adjusted their production capacities in response to demand fluctuations, necessitating the addition or relocation of machinery and equipment.

    The ongoing reshoring of manufacturing operations to the US is poised to be a pivotal factor in AIS’s long-term expansion, with anticipated similar relocation successes. In conjunction with forthcoming orders, AIS harbors the potential to achieve over 30% annual revenue growth in FY’24.

    Additionally, Cemtrex remains committed to exploring acquisition opportunities that can augment the company’s market presence and service capabilities, further catalyzing AIS’s growth trajectory.

  • Stronger Financials Drove Cemtrex (CETX) Stock Higher

    Stronger Financials Drove Cemtrex (CETX) Stock Higher

    Cemtrex, Inc. (NASDAQ: CETX) had a significant boost in trading on Thursday. Cemtrex stock closed the regular session on the US stock charts at $6.49 after rising 10.75%. The announcement of quarterly results sparked this spike in CETX share price.

    Cemtrex (CETX), in a press release yesterday, has unveiled its unaudited financial and operational results. The results so released were for the recently completed fourth quarter and fiscal year ended September 30, 2023.

    Remarkably, Cemtrex reached a significant sales milestone for FY’23, coming in at $59.7 million with a strong 33% increase over FY’22’s $45.0 million. Additionally, the quarterly sales showed a positive trend, rising to $16.9 million in Q4’23 from $11.8 million in Q4’22, a remarkable 44% increase.

    Also, CETX showed a notable improvement in its operational income, revealing a positive amount of $0.2 million for Q4 of 23. It was in stark contrast to the $3.1 million of operational loss the company faced in Q4 2022.

    The fourth quarter marked a robust conclusion to a transformative year for Cemtrex, characterized by substantial growth in the Security and Industrial segments. CETX concluded the year with significant revenue growth and improved gross margins, contributing to the third consecutive quarter of positive operating income.

    Collectively, Cemtrex’s endeavors in fortifying its subsidiary Vicon’s preeminent security technology brand, capitalizing on the escalating demand for security solutions, and monetization efforts for AIS, including the acquisition of Heisey Mechanical, coalesced to deliver a record fiscal year in 2023.

    For Cemtrex, 2023 has showcased sustained growth in the customer roster and revenue for its segments’ products and services, illustrating momentum that positions the company for an even more robust 2024. The next generation of Vicon’s state-of-the-art surveillance cameras and VMS software, coupled with its transition into a recurring revenue business model, is anticipated to drive additional market share gains.

    Alongside expanded services from the Heisey Mechanical acquisition, Cemtrex’s other subsidiary, Advanced Industrial Services (“AIS”), is well-positioned for ongoing growth. Looking forward, after achieving consecutive operating profits for the most recent three quarters, Cemtrex is resolute in its commitment to achieving positive operating income in fiscal year 2024 on a full-year basis.

  • Cemtrex, Inc. (CETX) Stock Among Stocks Being Targeted in Resurgence of Meme Stock Phenomenon

    Cemtrex, Inc. (CETX) Stock Among Stocks Being Targeted in Resurgence of Meme Stock Phenomenon

    Cemtrex, Inc. (CETX) stock prices continue their upward trend, having ended the July 9th, 2021 trading day at USD$1.49, a 13.64% increase. Subsequent premarket fluctuations have seen the stock rise another 15.44%, bringing it up to USD$1.72.

    Revenue Reports

    CETX reported USD$9.3 million in revenue for the quarter ended March 31st 2021, representing a year-over-year decrease of 24% from the USD$12.1 million reported for the same time period of 2020. The yearly difference is largely attributable to the devastating effects resulting from the onset of the coronavirus pandemic causing shutdowns and the limiting of business operations. The Advanced Technologies segment revenues for the quarter were down 11% to USD$5.5 million, while the Industrial Services segment revenues were down 36% to USD$3.8 million.

    Net Income Improvements

    Net income for the quarter was reported at USD$2.5 million for the quarter, up significantly from the net loss of USD$1.6 million reported in the prior year quarter. This year-over-year difference is largely attributable to various income items exclusive to the 2021 quarter, including a one-time settlement agreement, as well as unrealized gains on marketable securities.

    Traded Volume Increase

    The company reported cash and cash equivalents in the amount of USD$15.6 million as of March 31st 2021, indicating a comfortable liquidity position. Nevertheless, the steep climb of volume of shares traded from the low thousands to upwards of one million over a course of days is not adequately contextualized by the company’s recent financials. Rather, the absence of any other recent news or changes in fundamentals makes the stocks recent activity highly contentious.

    Meme Stock Phenomenon

    In the absence of recent developments, it seems likely that the stock finds itself the target of the meme stock phenomenon that has been captivating the markets again as of late. Driven by retail investors, the movement has seen underdog companies being targeted for a short-term pump and dump. Companies that indicate a high short interest find their stock prices being inflated artificially with little to no reason in the coordinated short squeeze. Rife with inherent risk and volatility, the movement is not consistent or reliable. Moreover, in most cases it seems a very large correction on a very short timeframe.

    Future Outlook for CETX

    Nevertheless, armed with the fortuitous surge in equity value provides the company the exposure to capitalize on the addition opportunities it finds at its disposal. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal to facilitate more organic growth over the long term.

  • Pre-Market Cues: 32 Stocks Roaring for Change On December 1st

    Pre-Market Cues: 32 Stocks Roaring for Change On December 1st

    China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio of electric power steering products for use in Chinese electric vehicles during 2020. The most recent rating by Brean Murray, on August 15, 2011, is a Hold.
    Before the trading started on December 01, 2020, G1 Therapeutics Inc. (GTHX) is up 4.05% to reach $19.0. It has been trading in a 52-week range of $8.80 to $31.38.
    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 29.83% at $0.947 at the time of writing following the announcement its elimination of senior secured second lien convertible notes. Company’s 52-week ranged between $0.14 to $3.88.
    Jaguar Health Inc. (JAGX) grew over 69.45% at $0.5929 in pre-market trading today.
    SuperCom Ltd. (SPCB) stock moved down -10.74 percent to $1.08 in the pre-market trading and the company recently declared that it has secured a contract to provide its PureSecurity Electronic Monitoring (EM) suite in Wisconsin.
    MicroStrategy Incorporated (NASDAQ: MSTR) shares are trading up 4.93% at $359.66 at the time of writing. Company’s 52-week ranged between $90.00 to $280.00. Analysts have a consensus price target of $200.
    Veritone Inc. (VERI) grew over 4.4% at $27.78 in pre-market trading today after announcing that it now supports NVIDIA CUDA for GPU-based AI and machine learning.
    Before the trading started on December 01, 2020, Creative Realities Inc. (CREX) is down -7.26% to reach $1.15. It has been trading in a 52-week range of $0.52 to $5.98.
    Moderna Inc. (MRNA) stock soared 10.32% to $168.5 in the pre-market trading after declaring that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The most recent rating by Wells Fargo, on November 23, 2020, is an Equal weight.
    VBI Vaccines Inc. (VBIV), a Biotechnology company, rose about 3.94% at $3.56 in pre-market trading Tuesday.
    Schultze Special Purpose Acquisition Corp. (SAMA) stock moved up 2.86 percent to $12.6 in the pre-market trading after reporting effectiveness of registration statement for proposed business combination with Clever Leaves International Inc.
    Celsion Corporation (CLSN) gained over 5.59% at $0.71 in pre-market trading Tuesday December 01, 2020.
    Nano-X Imaging Ltd. (NNOX) is up more than 5.22% at $64.5 in pre-market hours Tuesday December 01, 2020. The healthcare firm lately announced revised time of live demonstration at the 2020 radiology society of North America virtual annual meeting. The stock had jumped over 17.21% to $61.30 in the last trading session.
    Before the trading started on December 01, 2020, Greenlane Holdings Inc. (GNLN) is up 2.89% to reach $4.27. It has been trading in a 52-week range of $1.02 to $4.20.
    Mogo Inc. (MOGO) stock soared 3.77% to $2.75 in the pre-market trading. The firm recently declared the release of its new updated Mogo app featuring an interactive Rainforest Mode as part of the MogoCard experience. The most recent rating by Raymond James, on July 23, 2020, is an Outperform.
    Altimmune Inc. (NASDAQ: ALT) shares are trading up 9.57% at $13.4 at the time of writing. Company’s 52-week ranged between $1.60 to $35.10. Analysts have a consensus price target of $28.
    Novavax Inc. (NVAX) grew over 6.09% at $148.0 in pre-market trading today following publication its COVID-19 vaccine clinical development progress.
    Marathon Patent Group Inc. (MARA), a Capital Markets company, rose about 7.96% at $6.78 in pre-market trading Tuesday.
    Aphria Inc. (APHA) is up more than 3.46% at $8.67 in pre-market hours Tuesday December 01, 2020. The healthcare company recently revealed that it has closed the accretive, strategic acquisition of SW Brewing Company, LLC. The stock had jumped over 8.41% to $8.38 in the last trading session.
    AquaBounty Technologies Inc. (AQB) gained over 4.31% at $6.05 in pre-market trading Tuesday December 01, 2020.
    Before the trading started on December 01, 2020, ADMA Biologics Inc. (ADMA) is up 2.45% to reach $2.09 following the announcement its commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Maryville, Tennessee. It has been trading in a 52-week range of $1.45 to $4.95.
    CureVac N.V. (CVAC) is down more than -3.12% at $101.89 in pre-market hours Tuesday December 01, 2020. The stock had jumped over 22.29% to $105.17 in the last trading session.
    OrganiGram Holdings Inc. (OGI) gained over 4.26% at $1.47 in pre-market trading Tuesday December 01, 2020 after releasing its results for the fourth quarter ended August 31, 2020.
    FuelCell Energy Inc. (FCEL) is down more than -3.43% at $9.85 in pre-market hours Tuesday December 01, 2020. The stock had jumped over 5.26% to $10.20 in the last trading session.
    SSR Mining Inc. (SSRM) grew over 2.12% at $18.8 in pre-market trading today. The company lately publicized that positive results of the Çöpler District master plan studies.
    Before the trading started on December 01, 2020, Entasis Therapeutics Holdings Inc. (ETTX) is up 4.35% to reach $1.92. It has been trading in a 52-week range of $1.58 to $5.64.
    Luokung Technology Corp. (LKCO) is up more than 2.93% at $0.6 in pre-market hours Tuesday December 01, 2020 after the firm reported that it won bid for Heilongjiang Institute of Technology (“HIT”) Smart Campus first phase procurement project of USD 1.3 million. The stock had jumped over 4.09% to $0.58 in the last trading session.
    Riot Blockchain Inc. (RIOT) is up more than 3.55% at $8.75 in pre-market hours Tuesday December 01, 2020. The stock had jumped over 35.20% to $8.45 in the last trading session.
    Before the trading started on December 01, 2020, Dada Nexus Limited (DADA) is down -4.28% to reach $55.47 after declaring proposed follow-on public offering of American depositary shares. It has been trading in a 52-week range of $14.60 to $56.91.
    Logitech International S.A. (NASDAQ: LOGI) shares are trading down -3.3% at $87.32 at the time of writing. Company’s 52-week ranged between $31.37 to $95.71.
    Advaxis Inc. (ADXS), a Biotechnology company, rose about 11.86% at $0.33 in pre-market trading Tuesday. The biotechnology firm recently declared closing of $9.2 million public offering.
    Arbutus Biopharma Corporation (NASDAQ: ABUS) shares are trading up 11.26% at $5.04 at the time of writing. Company’s 52-week ranged between $0.88 to $9.02. Analysts have a consensus price target of $8.